LC-MS/MS is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-13. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
== Objectives == Gemini 4 would be the first multi-day space flight by the United States, designed to show that it was possible for humans to remain in space for extended lengths of time. The four-day, 66-orbit flight would approach but not break the five-day record set by the Soviet Vostok 5 in June 1963. Subsequent Gemini flights would be longer, to prove endurance exceeding the time required to fly to the Moon and back. A second objective was the first American extra-vehicular activity (EVA), known popularly as a "space walk". The first space walk had already been performed by Soviet Alexei Leonov on Voskhod 2 in March 1965. NASA moved up the spacewalk from the original schedule, to demonstrate that the US was gaining on the early lead taken by the Soviets in what was known as the Space Race. As late as 11 days before the scheduled June 3 launch, newspapers were reporting NASA saying that it "had not yet determined whether White would be the first American astronaut to expose himself to the elements of space" and that "A decision might not be made until a day or two before launching." A third objective was for Gemini 4 to attempt the first space rendezvous, flying in formation with the spent second stage of its Titan II launch vehicle.
== Signs and symptoms == Symptoms vary according to individuals' hydration level and sensitivity to the rate and/or magnitude of decline of their blood glucose concentration. A crash is usually felt within four hours of heavy carbohydrate consumption. Along with the symptoms of hypoglycemia, symptoms of reactive hypoglycemia include:
==== Ductal development ==== Though to a far lesser extent than estrogen, which is the major mediator of mammary ductal development (via the ERα), progesterone may also be involved in ductal development of the mammary glands to some extent. PR knockout mice or mice treated with the PR antagonist mifepristone show delayed although otherwise normal mammary ductal development at puberty. In addition, mice modified to have overexpression of PRA display ductal hyperplasia, and progesterone induces ductal growth in the mouse mammary gland. Progesterone mediates ductal development mainly via induction of the expression of amphiregulin, the same growth factor that estrogen primarily induces the expression of to mediate ductal development. These animal findings suggest that, while not essential for full mammary ductal development, progesterone seems to play a potentiating or accelerating role in estrogen-mediated mammary ductal development.
Sources: en.wikipedia.org
== Abstracting and indexing == Xenobiotica is abstracted and indexed in Biochemistry and Biophysics Citation Index, BIOSIS, Chemical Abstracts; Current Contents/Life Science, EBSCO, Science Citation Index, PASCAL, SciSearch, Scopus, and Index Medicus/MEDLINE/PubMed.
Truveta, Inc. is an American health data and analytics company headquartered in Bellevue, Washington and owned and governed by 30 U.S. health systems. Truveta was established in 2020 by Providence, Advocate Health, Tenet Healthcare, and Trinity Health. The company was publicly introduced in February 2021 with fourteen founding health system members. As of 2025, Truveta includes 30 U.S. health systems as members. Truveta provides de-identified electronic health record data for more than 120 million U.S. patients.
== History == Modern two-dimensional chromatographic techniques are based on the results of the early developments of paper chromatography and thin-layer chromatography (TLC) which involved liquid mobile phases and solid stationary phases. These techniques would later generate modern gas chromatography (GC) and liquid chromatography (LC) analysis. Different combinations of one-dimensional GC and LC produced the analytical chromatographic technique that is known as two-dimensional chromatography. The earliest form of 2D-chromatography came in the form of a multi-step TLC separation in which a thin sheet of cellulose is used first with one solvent in one direction, then, after the paper has been dried, another solvent is run in a direction at right angles to the first. This methodology first appeared in the literature with a 1944 publication by A. J. P. Martin and coworkers detailing an efficient method for separating amino acids – "...but the two-dimensional chromatogram is especially convenient, in that it shows at a glance information that can be gained otherwise only as the result of numerous experiments" (Biochem J., 1944, 38, 224).
Taghi allegedly wanted to kill Nabil B. as a punishment for being involved in killing the wrong person, which eventually led to Nabil B. collaborating with the Dutch authorities instead. As a result of this, Taghi ordered to kill Nabil B.'s innocent brother, who was a non-criminal, respected business owner in Amsterdam-Noord. Also Nabil B.'s lawyer Derk Wiersum was assassinated on the orders of Taghi, which eventually shocked the Netherlands. The Dutch parliament considered this as an attack on the Dutch legal system and the Dutch state, and a manhunt on Taghi by the Dutch authorities was eventually launched. In August 2020, six prominent lawyers in the Netherlands were accused of having delivered information to Ridouan Taghi's organisation in exchange for high sums of money. Their names were also added to the Marengo trials. T. Youssef one of Taghi's lawyers, and also his cousin, had been arrested on 8 October 2021, after being suspected of planning a jailbreak and smuggling messages out of prison to Taghi's organisation. In July 2021, the most prominent Dutch crime journalist Peter R. de Vries was assassinated after he left the studio of RTL Boulevard in Amsterdam, right after he appeared on a popular TV show. This assassination deeply shocked the Netherlands, with many politicians and celebrities sharing their condolences and speaking out on the increase of violence in the Netherlands. According to the Dutch authorities, all tracks lead to the already imprisoned Taghi.
Sources: en.wikipedia.org
The previous management team purchased the Australian Franchise System of Cold Rock in August 2002 and is attempting to present Cold Rock as the "premier ice cream franchise in Australia". In 2008, Cold Rock opened its eightieth store in Melbourne, Victoria. In September 2009, the Franchised Food Company, owned by businessman Stan Gordon, acquired all 87 Cold Rock ice-cream stores. In May 2017 Cold Rock launched "Super Kosher" ice creams and mix-ins. It was the first time an Australian franchising targeted its products for the Jewish/kosher market. In 2019, the chain was forced to close several stores due to rising costs, including stores in Indooroopilly and Springwood in Queensland, putting pressure on the franchise.
The dog is neither wholly carnivorous nor wholly herbivorous, but of a mixed kind, and can receive nourishment from either flesh or vegetables. A mixture of both is therefore his proper food, but of the former he requires a greater portion, and this portion should be always determined by his bodily exertions. It was not until the mid-1800s that the world saw its first food made specifically for dogs. An American electrician, James Spratt, concocted the first dog treat. Living in London at the time, he witnessed dogs around a shipyard eating scraps of discarded biscuits. Shortly thereafter he introduced his dog food, made up of wheat meals, vegetables and meat. By 1890 production had begun in the United States and became known as "Spratt's Patent Limited". In later years, dog biscuit was sometimes treated as synonymous with dog food:
The battle at Qalabane demoralized the Cape Mounted Yeomanry, which had previously successfully repulsed much larger bodies of enemy troops, but the Basuto hailed the clash as a great victory. Clarke reached Mafeteng, engaging in counter-insurgency operations in its vicinity until the end of the month before returning to the Cape.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.